Poland· PL-100069514
Urosal
A other urologicals product containing methenaminum + phenylis salicylas, registered in Poland by Zakłady Chemiczno-Farmaceutyczne "VIS" Sp. z o.o.. The same ATC class is registered in 7 of our 19 countries.
Checked against URPL (Poland) on
Informational only — not a medical device.
Where it is registered
Methenaminum + phenylis salicylas is registered in 7 of 19 countries.
Countries holding a registration under ATC G04BX (other urologicals), each read from that country’s own register.
- This record: Poland, from URPL (Poland)
- 6 of them publish a price we can compare per daily dose
Methenaminum + phenylis salicylas · ATC G04BX
7 / 19 countries
- Belgiumprice
- Czechiaprice
- Icelandprice
- Ireland
- Norwayprice
- Polandprice
- Switzerlandprice
The record
At a glance
URPL (Poland)- Active substance
- Methenaminum + Phenylis salicylas
- Manufacturer
- Zakłady Chemiczno-Farmaceutyczne "VIS" Sp. z o.o.
- Country
- Poland (PL)
- ATC code
- G04BX
- ATC class
- Other urologicals
- Reimbursed
- Not published by this register
- Source register
- URPL (Poland)
- Last checked
- September 27, 2026
Packs & prices · 2
- gtin05909990186419
- gtin05909990186426
Regulatory notes
No shortage, Orange Book or US label notes for this record.
Same class
Other records under G04BX
Other urologicals, as other registers publish it.
- SwitzerlandAmavita Nieren- und Blasendragées, FilmtablettenAmavita Health Care AG
- SwitzerlandAmavita Nieren- und Blasendragées, FilmtablettenAmavita Health Care AG
- SwitzerlandAngomed, FilmtablettenZeller Medical AG
- SwitzerlandAngomed, FilmtablettenZeller Medical AG
- SwitzerlandArkocaps Busserole nouvelle formule, gélulesArko Diffusion AG
- SwitzerlandArkocaps Orthosiphon 325 mg, gélulesArko Diffusion AG
- SwitzerlandArkocaps Orthosiphon 325 mg, gélulesArko Diffusion AG
- SwitzerlandArkocaps Orthosiphon 325 mg, gélulesArko Diffusion AG
Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of URPL (Poland). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.
For developers
The same record over the API, and the raw payload
GET /v1/drugs/c5cff7cd-7499-4af1-b59f-d46c5abe98ba GET /v1/drugs/c5cff7cd-7499-4af1-b59f-d46c5abe98ba?format=fhir
Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.
{
"form": "Tabletki",
"source": "urpl",
"strength": "300 mg + 300 mg",
"packaging": "05909990186419 ¦ OTC ¦ 10437\n20 tabl.\n05909990186426 ¦ OTC ¦ Skasowane ¦ 14345\n20 tabl. w butelce",
"substance": "Methenaminum 300 mg + Phenyli salicylas 300 mg",
"common_name": "Methenaminum + Phenylis salicylas",
"pl_product_id": "100069514",
"pozwolenie_nr": "01864",
"auth_procedure": "NAR",
"authorisation_validity": "Bezterminowe"
}See everything about methenaminum + phenylis salicylas.
This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.